Patents by Inventor Wesley Schaal

Wesley Schaal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indoles useful in the treatment of inflammation
    Patent number: 8097623
    Abstract: There is provided compounds of formula (I), wherein X1, Q, T, Y, R1, R2, R3, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: January 17, 2012
    Assignee: Biolipox AB
    Inventors: Benjamin Pelcman, Kristofer Olofsson, Martins Katkevics, Vita Ozola, Edgars Suna, Ivars Kalvins, Peteris Trapencieris, Dace Katkevica, Wesley Schaal
  • Bis Aromatic Compounds for Use in the Treatment of Inflammation
    Publication number: 20110294853
    Abstract: There is provided compounds of formula (I), wherein ring A, D1, D2a, D2b, D3, Y, Y1, L3 and Y3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.
    Type: Application
    Filed: September 10, 2009
    Publication date: December 1, 2011
    Inventors: Benjamin Pelcman, Maria Almeida, Martins Katkevics, Peter Nilsson, Wesley Schaal, Kristofer Olofsson
  • Indoles Useful in the Treatment of Inflammation
    Publication number: 20100197687
    Abstract: There is provided compounds of formula I, wherein T, Y, X1, R1, R2, R3, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: December 22, 2005
    Publication date: August 5, 2010
    Inventors: Benjamin Pelcman, Kristofer Olofsson, Martins Katkevics, Vita Ozola, Edgars Suna, Ivars Kalvins, Peteris Trapencieris, Dace Katkevica, Wesley Schaal
  • Benzoxazoles Useful in the Treatment of Inflammation
    Publication number: 20100004301
    Abstract: There is provided the use of a compound of formula I, wherein Y, W1 to W4, Z1 to Z4 and R have meanings given in the description, and pharmaceutically-acceptable salts thereof, for the manufacture of a medicament for the treatment of a disease in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: December 12, 2007
    Publication date: January 7, 2010
    Inventors: Benjamin Pelcman, Kristofer Olofsson, Ivars Kalvins, Edgars Suna, Vita Ozola, Wesley Schaal
  • Benzoxazoles Useful in the Treatment of Inflammation
    Publication number: 20090258917
    Abstract: There is provided the use of a compound of formula I, wherein Y, W1 to W4, Z1 to Z4 and R have meanings given in the description, and pharmaceutically-acceptable salts thereof, for the manufacture of a medicament for the treatment of a disease in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: October 12, 2006
    Publication date: October 15, 2009
    Inventors: Benjamin Pelcman, Kristofer Olofsson, Wesley Schaal, Ivars Kalvins, Martins Katkevics, Vita Ozola, Edgars Suna
  • Indoles Useful in the Treatment of Inflammation
    Publication number: 20090076004
    Abstract: There is provided compounds of formula (I), wherein X1, Q, T, Y, R1, R2, R3, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: December 22, 2005
    Publication date: March 19, 2009
    Inventors: Benjamin Pelcman, Kristofer Olofsson, Martins Katkevics, Vita Ozola, Edgars Suna, Ivars Kalvins, Peteris Trapencieris, Dace Katkevica, Wesley Schaal
  • Indoles Useful in the Treatment of Inflammation
    Publication number: 20090042949
    Abstract: There is provided compounds of formula I, wherein X1, T, Y, R1, R2, R3, R4 and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: December 22, 2005
    Publication date: February 12, 2009
    Inventors: Benjamin Pelcman, Kristofer Olofsson, Martins Katkevics, Vita Ozola, Edgars Suna, Ivars Kalvins, Wesley Schaal
  • Use of New Lipoxygenase Inhibitors
    Publication number: 20080227787
    Abstract: There is provided a use of a compound of formula (I), wherein R1, R2, R3 and R4 have meanings given in the description, and pharmaceutically-acceptable salts thereof, for the manufacture of a medicament for the treatment of a disease in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: March 2, 2005
    Publication date: September 18, 2008
    Inventors: Kristofer Olofsson, Benjamin Pelcman, Peter Nilsson, Anders Hallberg, Wesley Schaal
  • Indoles Useful in the Treatment of Inflammation
    Publication number: 20080188473
    Abstract: There is provided a compound of formula: (I) wherein X, R1, R2, R3, R4, R5, R6, R7 and R8 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of microsomal prostaglandin E synthase-1 is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: June 17, 2005
    Publication date: August 7, 2008
    Inventors: Kristofer Olofsson, Benjamin Pelcman, Wesley Schaal, Ivars Kalvins, Edgars Suna, Vita Ozola, Martins Katkevics
  • Indoles Useful in the Treatment of Inflammation
    Publication number: 20080146616
    Abstract: There is provided a compound of formula (I), wherein X, R1, R2, R3, R4, R5 and R6 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of microsomal prostaglandin E synthase-1 is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: June 17, 2005
    Publication date: June 19, 2008
    Inventors: Kristofer Olofsson, Benjamin Pelcman, Wesley Schaal, Ivars Kalvins, Edgars Suna, Vita Ozola, Martins Katkevics
  • Pyrazole compounds useful in the treatment of inflammation
    Publication number: 20060183780
    Abstract: There is provided a compound of formula (I), wherein R1, R2, R3, X and Y have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15-lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: March 12, 2004
    Publication date: August 17, 2006
    Inventors: Anders Hallberg, Wesley Schaal, Mats Larhed, Kristofer Olofsson, Benjamin Pelcman, Andrei Sanin
  • Indoles useful in the treatment of inflammation
    Publication number: 20060160879
    Abstract: There is provided a compound of formula (I), wherein X, Y, Z, R1, R2, R3, R4, and R5 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of microsomal prostaglandin E synthase-1 is desired and/or required, and particularly in the treatment of inflammation.
    Type: Application
    Filed: July 9, 2004
    Publication date: July 20, 2006
    Inventors: Kristofer Olofsson, Edgars Suna, Benjamin Pelcman, Vita Ozola, Martins Katkevics, Ivars Kalvins, Wesley Schaal